Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

v3.19.3.a.u2
Interim Segment Information (Tables)
9 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Segment information
Segment information for the three and nine months ended December 31, 2019, and 2018, is set forth below: 
 
 
Three months ended December 31, 2019
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
2,466

 
$
2,456

 
$
2,237

 
$
7,159

Cost of revenue
 
1,657


991

 
1,731

 
4,379

Gross profit
 
809

 
1,465

 
506

 
2,780

Gross margin
 
32.8
%
 
59.6
%
 
22.6
%
 
38.8
%
Research and development
 
470

 
505

 
247

 
1,222

Segment profit
 
$
339

 
$
960

 
$
259

 
1,558

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
1,556

General and administrative
 
 
 
 
 
 
 
1,093

Intangible amortization
 
 
 
 
 
 
 
308

Restructuring
 
 
 
 
 
 
 
234

Operating profit (loss)
 
 
 
 
 
 
 
(1,633
)
Other income, net
 
 
 
 
 
 
 
109

Income tax benefit (expense)
 
 
 
 
 
 
 
(20
)
Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(1,544
)
 
 
 
 
 
 
 
 
 
 
 
Three months ended December 31, 2018
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
2,794

 
$
5,116

 
$
2,812

 
$
10,722

Cost of revenue
 
1,725

 
2,217

 
2,190

 
6,132

Gross profit
 
1,069

 
2,899

 
622

 
4,590

Gross margin
 
38.3
%
 
56.7
%
 
22.1
%
 
42.8
%
Research and development
 
682

 
570

 
484

 
1,736

Segment profit
 
$
387

 
$
2,329

 
$
138

 
2,854

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
1,999

General and administrative
 
 
 
 
 
 
 
1,738

Intangible amortization
 
 
 
 
 
 
 
830

Operating profit (loss)
 
 
 
 
 
 
 
(1,713
)
Other income, net
 
 
 
 
 
 
 
158

Income tax benefit (expense)
 
 
 
 
 
 
 
(1
)
Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(1,556
)
 
 
Nine months ended December 31, 2019
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
8,007

 
$
8,197

 
$
7,526

 
$
23,730

Cost of revenue
 
5,813


4,111

 
6,201

 
16,125

Gross profit
 
2,194

 
4,086

 
1,325

 
7,605

Gross margin
 
27.4
%
 
49.8
%
 
17.6
%
 
32.0
%
Research and development
 
1,272

 
1,825

 
1,130

 
4,227

Segment profit
 
$
922

 
$
2,261

 
$
195

 
3,378

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
6,147

General and administrative
 
 
 
 
 
 
 
3,706

Intangible amortization
 
 
 
 
 
 
 
924

Restructuring
 
 
 
 
 
 
 
234

Operating profit (loss)
 
 
 
 
 
 
 
(7,633
)
Other income, net
 
 
 
 
 
 
 
398

Income tax benefit (expense)
 
 
 
 
 
 
 
(27
)
Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(7,262
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine months ended December 31, 2018
(in thousands)
 
IBW
 
ISM
 
CNS
 
Total
Revenue
 
$
9,997

 
$
13,506

 
$
10,362

 
$
33,865

Cost of revenue
 
5,574

 
6,237

 
7,336

 
19,147

Gross profit
 
4,423

 
7,269

 
3,026

 
14,718

Gross margin
 
44.2
%

53.8
%
 
29.2
%
 
43.5
%
Research and development
 
2,071

 
1,697

 
1,243

 
5,011

Segment profit (loss)
 
$
2,352

 
$
5,572

 
$
1,783

 
9,707

Operating expenses:
 
 
 
 
 
 
 
 
Sales and marketing
 
 
 
 
 
 
 
6,012

General and administrative
 
 
 
 
 
 
 
4,672

Intangible amortization
 
 
 
 
 
 
 
2,652

Operating profit (loss)
 
 
 
 
 
 
 
(3,629
)
Other income, net
 
 
 
 
 
 
 
442

Income tax benefit (expense)
 
 
 
 
 
 
 
(11
)
Net income (loss) from continuing operations
 
 
 
 
 
 
 
$
(3,198
)